Portfolio
A sample of published works
Disease management
-
Kim ES, Fung S. Consider topical superpotent corticosteroids for oral lichen planus; reserve systemic therapy for severe disease. Drugs Ther Perspect. 2025;41(4):135–140. doi:10.1007/s40267-025-01146-4
-
Kim ES, Fung S. Management of orofacial pain starts with careful differentiation of odontogenic and non-odontogenic pain. Drugs Ther Perspect. 2024;40(7):256–263. doi:10.1007/s40267-024-01087-4
-
Kim ES, Lamb YN. Treat borderline personality disorder with psychotherapy and concomitant psychiatric disorders with adjuvant pharmacotherapy. Drugs Ther Perspect. 2024;40(1):17–21. doi:10.1007/s40267-023-01042-9
Practical issues and updates
-
Kim ES, Fung S. Neoantigen melanoma therapy has the potential to advance melanoma therapy and improve patient outcomes. Drugs Ther Perspect. 2026;42:84–88. doi:10.1007/s40267-025-01214-9
-
Kim ES, Zhuang-Yan A. Keep up to date with new biologics emerging for moderate-to-severe atopic dermatitis. Drugs Ther Perspect. 2025;41(11-12):510–514. doi:10.1007/s40267-025-01204-x
-
Kim ES, Fung S. Consider newly available agents for the treatment of refractory or unexplained chronic cough. Drugs Ther Perspect. 2025;41(6):261–265. doi:10.1007/s40267-025-01161-5
-
Kim ES, Kang C. Consider using a broad-spectrum sunscreen daily to prevent photoaging. Drugs Ther Perspect. 2022;38(6):268–273. doi:10.1007/s40267-022-00920-y
Drug evaluations
-
Kim ES. Oxycodone/naloxone prolonged release: a review in severe chronic pain. Clin Drug Investig. 2017;37(12):1191–1201. doi:10.1007/s40261-017-0593-1
-
Kim ES. Fampridine prolonged release: a review in multiple sclerosis patients with walking disability. Drugs. 2017;77(14):1593–1602. doi:10.1007/s40265-017-0808-z
Drug development summaries
-
Kim ES. Abemaciclib: first global approval. Drugs. 2017;77(18):2063–2070. doi:10.1007/s40265-017-0840-z
-
Kim ES. Valbenazine: first global approval. Drugs. 2017;77(10):1123–1129. doi:10.1007/s40265-017-0770-9
Drug reactions and interactions
-
Kim ES, Kang C. Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis. Drugs Ther Perspect. 2024;40(4):141–144. doi:10.1007/s40267-024-01064-x
-
Kim ES, Kang C. Risk of falls and fractures does not necessarily preclude the use of antihypertensive medications. Drugs Ther Perspect. 2023;39(6):212–215. doi:10.1007/s40267-023-00999-x
Medication guides
-
Kim ES, Al-Salama ZT. Somatrogon in paediatric growth hormone deficiency: a profile of its use in the EU. Drugs Ther Perspect. 2022;38(12):501–507. doi:10.1007/s40267-022-00955-1
-
Kim ES, Al-Salama ZT. Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA. Drugs Ther Perspect. 2022;38(9):382–388. doi:10.1007/s40267-022-00939-1